Stay updated with breaking news from Robert Ajer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Robert W. Baird downgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from an outperform rating to a neutral rating in a research note released on Friday morning, Marketbeat reports. The brokerage currently has $72.00 target price on the biotechnology company’s stock, down from their previous target price of $104.00. Several other brokerages have also […]
Evercore ISI began coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) in a research report report published on Tuesday, Marketbeat reports. The firm issued an outperform rating and a $113.00 price target on the biotechnology company’s stock. Several other equities research analysts have also recently issued reports on BMRN. Wells Fargo & Company […]
Motley Fool Wealth Management LLC reduced its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 3.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 470,289 shares of the biotechnology company’s stock after selling 18,667 shares during the quarter. […]
BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price objective decreased by Morgan Stanley from $115.00 to $112.00 in a research note released on Friday, Benzinga reports. Morgan Stanley currently has an overweight rating on the biotechnology company’s stock. Several other equities research analysts have also recently weighed in on the company. Cantor Fitzgerald reaffirmed […]
BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its target price lowered by Citigroup from $94.00 to $91.00 in a research note published on Thursday morning, Benzinga reports. Citigroup currently has a neutral rating on the biotechnology company’s stock. Several other research analysts have also issued reports on BMRN. Royal Bank of Canada restated a sector […]